<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="166468">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01876498</url>
  </required_header>
  <id_info>
    <org_study_id>Brief MHQ1</org_study_id>
    <secondary_id>Dupuytren 1</secondary_id>
    <nct_id>NCT01876498</nct_id>
  </id_info>
  <brief_title>Registry of Patient With M. Dupuytren and Validation of the Brief MHQ</brief_title>
  <official_title>Buildup of a Registry of Patient With M. Dupuytren and Validation of the Brief Michigan Hand Questionnaire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schulthess Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Schulthess Klinik</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the validation of the Brief Michigan Hand Questionnaire by
      patient with Morbus Dupuytren and to build up a register.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      examination of the characteristics of Patient with Morbus Dupuytren and the psychometric
      properties of the Brief Michigan Hand Questionnaire by this patients
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Brief Michigan Hand Questionnaire</measure>
    <time_frame>6 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient reported outcome measurement by hand disorders</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Joint mobility</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measuring the joint mobility of the fingers with the goniometer</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measuring pain with the Numeric rating scale</description>
  </other_outcome>
  <other_outcome>
    <measure>Grip Strength</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measuring grip strength with the dynamometer</description>
  </other_outcome>
  <other_outcome>
    <measure>Quick DASH</measure>
    <time_frame>3 year</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient reported outcome measurement by arm, shoulder and hand disorders</description>
  </other_outcome>
  <other_outcome>
    <measure>Euroqol 5l5d</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>analysis of the costs and utilities</description>
  </other_outcome>
  <other_outcome>
    <measure>Michigan Hand Questionnaire</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patient reported outcome measurement by hand disorders</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Dupuytren Contracture</condition>
  <condition>Collagen Shrinkage</condition>
  <condition>CRF</condition>
  <arm_group>
    <arm_group_label>Patient with M. Dupuytren</arm_group_label>
    <description>Xiaflex Surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Xiaflex surgery</intervention_name>
    <description>Xiaflex surgery</description>
    <arm_group_label>Patient with M. Dupuytren</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with M.Dupuytren with Xiapex injection or surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  M.Dupuytren, over 18y, able to speak and understand german

        Exclusion Criteria:

          -  recurrence, pregnancy, incapable of contracting
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Herren, Dr. med.</last_name>
    <role>Study Chair</role>
    <affiliation>Schulthess Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Schulthess Klinik</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Herren, Dr.med.</last_name>
      <phone>+41(0)443857481</phone>
      <email>daniel.herren@kws.ch</email>
    </contact>
    <investigator>
      <last_name>Daniel Herren, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 26, 2014</lastchanged_date>
  <firstreceived_date>June 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Schulthess Klinik</investigator_affiliation>
    <investigator_full_name>Daniel Herren</investigator_full_name>
    <investigator_title>Dr. med. Daniel Herren</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
